{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:30Z","timestamp":1786984410078,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017003","name":"Peking University Health Science Center","doi-asserted-by":"publisher","award":["BMU2023YJ016"],"award-info":[{"award-number":["BMU2023YJ016"]}],"id":[{"id":"10.13039\/501100017003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017003","name":"Peking University Health Science Center","doi-asserted-by":"publisher","award":["BMU2021RCZX013"],"award-info":[{"award-number":["BMU2021RCZX013"]}],"id":[{"id":"10.13039\/501100017003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2306902"],"award-info":[{"award-number":["2023YFC2306902"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172251"],"award-info":[{"award-number":["82172251"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372236"],"award-info":[{"award-number":["82372236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570710"],"award-info":[{"award-number":["82570710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32450370"],"award-info":[{"award-number":["32450370"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.antiviral.2026.106359","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:38:18Z","timestamp":1769701098000},"page":"106359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["SOX6 is a novel host factor that promotes hepatitis B virus replication by enhancing the transcriptional activity of enhancer I"],"prefix":"10.1016","volume":"247","author":[{"given":"Yarong","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuanhui","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6518-948X","authenticated-orcid":false,"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106359_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.critrevonc.2015.10.017","article-title":"Hepatitis B and cancer: a practical guide for the oncologist","volume":"98","author":"Bozza","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.antiviral.2026.106359_bib2","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood-2010-04-282350","article-title":"Sox6 enhances erythroid differentiation in human erythroid progenitors","volume":"117","author":"Cant\u00f9","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2026.106359_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.freeradbiomed.2018.12.008","article-title":"Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS\/JNK and inhibition of the Akt\/mTOR pathway","volume":"131","author":"Chen","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.antiviral.2026.106359_bib4","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/jhep.2003.50220","article-title":"Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma","volume":"37","author":"Cheng","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106359_bib5","first-page":"480","article-title":"Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review","volume":"31","author":"Cholongitas","year":"2018","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.antiviral.2026.106359_bib6","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1541-7786.MCR-09-0112","article-title":"Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy","volume":"7","author":"Chung","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.antiviral.2026.106359_bib7","article-title":"Hepatitis B virus reactivation following treatment of HNSCC with Cisplatin","volume":"10","author":"Crosby","year":"2022","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.antiviral.2026.106359_bib8","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1177\/1078155220964256","article-title":"Fatal hepatitis B reactivation in a patient receiving chemoradiation for cervical cancer","volume":"27","author":"Dimond","year":"2021","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.antiviral.2026.106359_bib9","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1128\/MCB.24.4.1799-1808.2004","article-title":"Enhancer I predominance in hepatitis B virus gene expression","volume":"24","author":"Doitsh","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2026.106359_bib10","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1128\/JVI.00254-08","article-title":"In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses","volume":"82","author":"Grimm","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106359_bib11","first-page":"3035","article-title":"Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy","volume":"24","author":"Hsu","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.antiviral.2026.106359_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41419-021-04474-1","article-title":"MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer","volume":"13","author":"Huang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.antiviral.2026.106359_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41420-024-01834-6","article-title":"SOX on tumors, a comfort or a constraint?","volume":"10","author":"Jiang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.antiviral.2026.106359_bib14","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1242\/dev.091793","article-title":"Sox proteins: regulators of cell fate specification and differentiation","volume":"140","author":"Kamachi","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.antiviral.2026.106359_bib15","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.14309\/ajg.0000000000002185","article-title":"A prospective study of preemptive tenofovir disoproxil fumarate therapy in HBsAg-Positive patients with diffuse large B-Cell lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"118","author":"Kim","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2026.106359_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jhep.2017.08.033","article-title":"Identification of Slug and SOX7 as transcriptional repressors binding to the hepatitis B virus core promoter","volume":"68","author":"Ko","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106359_bib17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12072-021-10239-x","article-title":"APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy","volume":"15","author":"Lau","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.antiviral.2026.106359_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-981-13-9151-4_5","article-title":"Cell culture models and animal models for HBV study","volume":"1179","author":"Li","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2026.106359_bib19","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1038\/s41598-018-21847-3","article-title":"Cisplatin enhances hepatitis B virus replication and PGC-1\u03b1 expression through endoplasmic reticulum stress","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2026.106359_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2189676","article-title":"C2729T mutation associated with HBV mother-to-child transmission reduces HBV production via suppressing LHBs expression","volume":"14","author":"Liu","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.antiviral.2026.106359_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16882-5","article-title":"A robust cell culture system supporting the complete life cycle of hepatitis B virus","volume":"7","author":"Michailidis","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2026.106359_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","article-title":"Epidemiology of hepatitis B virus infection and impact of vaccination on disease","volume":"20","author":"Nelson","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.antiviral.2026.106359_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3350\/cmh.2016.0024","article-title":"Prevention of hepatitis B reactivation in the setting of immunosuppression","volume":"22","author":"Pattullo","year":"2016","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106359_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2016.05.043","article-title":"Aiming for cure in HBV and HDV infection","volume":"65","author":"Petersen","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106359_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.stem.2012.12.007","article-title":"The sox family of transcription factors: versatile regulators of stem and progenitor cell fate","volume":"12","author":"Sarkar","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.antiviral.2026.106359_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep10066","article-title":"Hepatitis B virus replication and sex-determining region Y box 4 production are tightly controlled by a novel positive feedback mechanism","volume":"5","author":"Shang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2026.106359_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104745","article-title":"Sex-determining region Y box 4 (SOX4) suppresses Hepatitis B virus replication by inhibiting hepatocyte nuclear factor 4\u03b1 expression","volume":"176","author":"Shi","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106359_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/346240a0","article-title":"A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif","volume":"346","author":"Sinclair","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106359_bib29","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/v14091887","article-title":"HBx 128-133 deletion affecting HBV mother-to-child transmission weakens HBV replication via reducing HBx level and CP\/ENII transcriptional activity","volume":"14","author":"Song","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106359_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(82)90157-X","article-title":"Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate","volume":"29","author":"Summers","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2026.106359_bib31","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1128\/JVI.06064-11","article-title":"Autophagy required for hepatitis B virus replication in transgenic mice","volume":"85","author":"Tian","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106359_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-981-13-9151-4_2","article-title":"HBV genome and life cycle","volume":"1179","author":"Wang","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2026.106359_bib33","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/cam4.1468","article-title":"RFX1 participates in doxorubicin-induced hepatitis B virus reactivation","volume":"7","author":"Wang","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.antiviral.2026.106359_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13131","article-title":"AMPK and Akt\/mTOR signalling pathways participate in glucose-mediated regulation of hepatitis B virus replication and cellular autophagy","volume":"22","author":"Wang","year":"2020","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2026.106359_bib35","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/nar\/27.6.1409","article-title":"From head to toes: the multiple facets of Sox proteins","volume":"27","author":"Wegner","year":"1999","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2026.106359_bib36","series-title":"Global Hepatitis Report 2024","year":"2024"},{"key":"10.1016\/j.antiviral.2026.106359_bib37","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/gut.2009.195834","article-title":"Managing HBV in patients with impaired immunity","volume":"59","author":"Wursthorn","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2026.106359_bib38","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3892\/mmr.2014.1973","article-title":"Epirubicin directly promotes hepatitis B virus (HBV) replication in stable HBV-expressing cell lines: a novel mechanism of HBV reactivation following anticancer chemotherapy","volume":"9","author":"Xu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.antiviral.2026.106359_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/v12030273","article-title":"SOX2 represses hepatitis B virus replication by binding to the viral EnhII\/Cp and inhibiting the promoter activation","volume":"12","author":"Yang","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106359_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104761","article-title":"SOX9 represses hepatitis B virus replication through binding to HBV EnhII\/Cp and inhibiting the promoter activity","volume":"177","author":"Yang","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106359_bib41","article-title":"Anticodon engineered transfer RNA (tRNASUAG) inhibits hepatitis B virus replication by promoting the degradation of core protein","volume":"12","author":"Yang","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.antiviral.2026.106359_bib42","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/1878-0261.13613","article-title":"MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGF\u03b22-Smad2\/3 signaling pathway in cervical cancer","volume":"18","author":"Zheng","year":"2024","journal-title":"Mol. Oncol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:13:48Z","timestamp":1771424028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"alternative-id":["S0166354226000185"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106359","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SOX6 is a novel host factor that promotes hepatitis B virus replication by enhancing the transcriptional activity of enhancer I","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106359"}}